When cases with either NOTCH1 mutations or RBPJ alterations were considered together, the combined group was more strongly associated with disease progression and pathway inactivation than either one alone, and was strongly associated with worse PFS, again raising the possibility that Notch pathway inactivation by multiple mechanisms may be associated with oligodendroglioma progression. This evidence concerns the gene NOTCH1 and oligodendroglioma.